Manchester, UK – 6 April 2021: Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that it has signed a COVID-19 testing services agreement with its partner MyHealthChecked plc (AIM: MHC) (“MyHealthChecked”) to support their newly announced partnership with Boots UK Limited (“Boots”), the health and beauty retailer and pharmacy group. Through the service agreement, a proportion of the MyHealthChecked™ COVID-19 tests will be processed by Yourgene Genomic Services (“YGS”) at the Company’s Citylabs 1.0 laboratory in Manchester, which is well equipped to manage the increased demand. In addition, samples processed at MHC’s own laboratories are already using Yourgene’s Clarigene SARS CoV-2 PCR CE-IVD test kit.
The MyHealthChecked™ COVID-19 at-home nasal swab kit and PCR laboratory testing service will be promoted online and in Boots stores across Great Britain, allowing customers to take a nasal swab themselves at home and send samples safely and securely via the Royal Mail Tracked 24 service to be tested using established laboratory-based PCR detection methods. Yourgene’s Manchester based laboratories will be used to undertake testing and results are provided within 24-48 hours, via an online portal.
Volumes are unquantified at this stage until lockdown restrictions ease. The general testing and Fit to Fly service will be launched online shortly and promoted across over 507 stores in England, Wales and Scotland from April.
Lyn Rees, CEO of Yourgene Health and Non-Executive Director of MyHealthChecked, commented: “I would like to congratulate MyHealthChecked on this agreement with Boots and we look forward to supporting their COVID-19 testing service and product supply to their laboratory. COVID-19 PCR tests have become a travel essential and as we anticipate the return of international travel later in the year, we expect to see an increase in demand which we are well positioned to deal with.”
This announcement contains inside information for the purposes of the UK Market Abuse Regulation. The Directors of the Company take responsibility for this announcement.